-
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
Study
EGAS00001000942
-
CGA test: The BC Cancer Agency's Personalized Onco-Genomics Project
Study
EGAS50000000409
-
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma
Study
EGAS00001007426
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (ChIP-seq)
Study
EGAS00001006017
-
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Study
EGAS00001007911
-
Establishment and characterization of circulating tumor cells-derived organoids from metastatic breast cancer patients.
Study
EGAS00001007582
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
Characterization of alternative promoter usage in advanced prostate cancer
Study
EGAS00001006275
-
The impact of mutational clonality in predicting the response to anti-PD-L1/PD-L1 in advanced urothelial cancer
Study
EGAS00001007086
-
Prospective high-throughput genome profiling in advanced cancers:
Study
EGAS00001004554